Brief: GenSight Biologics Withdraws Its EMA Application For LUMEVOQ®

Gensight Biologics SA

20/04/2023 15:23

April 20 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS WITHDRAWS ITS EMA APPLICATION FOR
LUMEVOQ®
    * COMPANY IS EXPLORING OPTIONS INCLUDING GENERATING NEW
CLINICAL
DATA, WHICH MAY INDUCE MATERIAL DELAYS AND ADDITIONAL COSTS
    * CONFIRMS THAT MANUFACTURING VALIDATION CAMPAIGN IS ON
TRACK WITH
ITS PARTNER IN UNITED-STATES

Source text for Eikon:  ID:nBw6L6HnHa 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))